First Trust Advisors LP Ocular Therapeutix, Inc Transaction History

First Trust Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$4.83 - $7.35 $140,374 - $213,613	-29,063 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$6.16 - $12.07 $214,565 - $420,422	-34,832 Reduced 54.51%	29,063 $203,000
Q3 2021 Nov 15, 2021	SELL	$9.7 - $14.34 $1.24 Million - $1.84 Million	-127,994 Reduced 66.7%	63,895 $639,000
Q2 2021 Aug 16, 2021	BUY	$13.43 - $19.16 $2.15 Million - $3.06 Million	159,739 Added 496.86%	191,889 $2.72 Million
Q1 2021 May 14, 2021	BUY	$15.82 - $22.11 $508,613 - $710,836	32,150 New	32,150 $528,000

172

138M

150K

225K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $705M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.